The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.27
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 14.27
CLLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update

17 Nov 2017 07:02

RNS Number : 8037W
Carillion PLC
17 November 2017
 

17 November 2017

Update on discussions with stakeholders, trading and financial covenants deferral

Carillion plc ("Carillion" or "the Group") today provides an update on discussions with its financial stakeholders, trading and its intention to seek to defer the testing of its financial covenants.

Since July, the Group has been focused on reducing costs, collecting cash, executing its disposals programme and implementing its new operating model. These self-help measures will serve to reduce the Group's average net debt over time, but they will not be sufficient to enable the Group to achieve its target net debt to EBITDA ratio of between 1.0 to 1.5 times by the end of 2018. The Board is therefore in discussions with stakeholders regarding a broad range of options to further reduce net debt and repair and strengthen the Group's balance sheet. This will require some form of recapitalisation, which could involve a restructuring of the balance sheet. The Board expects to commence steps to implement the chosen option during the first quarter of 2018 and a further announcement will be made in due course.

In its interim results on 29 September 2017, Carillion confirmed that it was forecast to be in compliance with its financial covenants as at 31 December 2017. As then indicated, compliance with its financial covenants was dependent on achieving its underlying forecasts, which assume that the normal pattern of receipts and payments continue alongside the completion of a number of PPP disposals and settlement receipts on contracts.

The Board has kept under continuous review the risk that receipts from contract claims and/or disposals forecast to be received during November and December 2017 might slip beyond 31 December 2017. The Group now expects that a combination of delays to certain PPP disposals, a slippage in the commencement date of a significant project in the Middle East and lower than expected margin improvements across a small number of UK Support Services contracts, partially offset by cost savings initiatives realised in the fourth quarter, will lead to profits for the year to 31 December 2017 being materially lower than current market expectations. Given the impact of delays in receipts and disposals, the Group now expects full year average net borrowing in 2017 to be between £875m and £925m.

Based on its latest forecasts, reflecting the items mentioned above, the Board now expects a covenant breach as at 31 December 2017. Following discussions with its principal lenders and with their support, the Board has concluded that it is necessary to amend the relevant agreements to defer the test date for both its financial covenants from 31 December 2017 to 30 April 2018 (based on EBITDA for the 12 months to that date), by which time it expects to be implementing its recapitalisation plan. Carillion has now commenced a process to seek the consents necessary to make this amendment.

Commenting, Interim Chief Executive, Keith Cochrane said:

"Whilst we continue to target cash collections, reduce costs, execute disposals and focus on delivering for our customers, it is clear that significant challenges remain and more needs to be done to reduce net debt and rebuild the balance sheet. Constructive dialogue is continuing with our financial stakeholders, and I am grateful for their support. I remain focused on addressing this issue before my successor, Andrew Davies, takes up the role on 2 April 2018."

This and other Carillion news releases can be found at www.carillionplc.com.

 

For more information

Kellie McAvoy, Head of Investor Relations, or,

John Denning, Director Group Corporate Affairs, Carillion plc +44 (0) 1902 906333

 

 

 

Teneo Blue Rubicon

Fraser Hardie/Charles Armitstead/Haya Herbert-Burns +44 (0) 207 420 3197

 

Notes to editors

 

Financial covenants

Certain of Carillion's financing arrangements contain financial covenants that leverage (net debt / EBITDA) will be no more than 3.5 times and that interest cover (trading cashflow / net interest pre-IAS 19 charges) will be not less than 3.5 times.

 

Financing arrangements

The relevant financing arrangements are Carillion's senior additional funding facilities, syndicated revolving credit facility, private placement notes, Schuldschein loans, committed bonding lines and committed bilateral facilities.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXFXFEEXFEF
Date   Source Headline
13th Jul 20174:30 pmRNSHolding(s) in Company
13th Jul 20174:02 pmRNSHolding(s) in Company
13th Jul 20179:25 amRNSHolding(s) in Company
13th Jul 20179:22 amRNSHolding(s) in Company
10th Jul 20177:00 amRNSDirectorate Change
10th Jul 20177:00 amRNSTrading Statement
6th Jul 20174:58 pmRNSHolding(s) in Company
30th Jun 201711:08 amRNSDirectorate Change
19th Jun 20179:07 amRNSBlock listing Interim Review
16th Jun 20174:25 pmRNSHolding(s) in Company
16th Jun 20174:21 pmRNSHolding(s) in Company
16th Jun 20172:26 pmRNSHolding(s) in Company
15th Jun 20177:20 amRNSHolding(s) in Company
14th Jun 20179:08 amRNSDirector/PDMR Shareholding
13th Jun 20174:53 pmRNSHolding(s) in Company
13th Jun 20172:20 pmRNSDirector/PDMR Shareholding
5th Jun 20172:50 pmRNSHolding(s) in Company
1st Jun 20174:25 pmRNSHolding(s) in Company
30th May 20178:07 amRNSHolding(s) in Company
22nd May 20172:38 pmRNSHolding(s) in Company
22nd May 201711:49 amRNSHolding(s) in Company
18th May 20173:25 pmRNSHolding(s) in Company
17th May 20172:15 pmRNSHolding(s) in Company
16th May 201711:47 amRNSHolding(s) in Company
10th May 20177:38 amRNSDirector/PDMR Shareholding
8th May 20173:53 pmRNSHolding(s) in Company
4th May 20172:32 pmRNSHolding(s) in Company
4th May 201710:55 amRNS2017 AGM Results
4th May 20178:29 amRNSHolding(s) in Company
3rd May 201711:57 amRNSAGM Statement
28th Apr 201712:53 pmRNSDirector Declaration
18th Apr 20179:09 amRNSHolding(s) in Company
18th Apr 20177:30 amRNSDirector/PDMR Shareholding
13th Apr 201711:19 amRNSHolding(s) in Company
12th Apr 20177:00 amRNSCarillion selected as preferred bidder
11th Apr 20174:19 pmRNSDirector/PDMR Shareholding
11th Apr 20174:13 pmRNSDirector/PDMR Shareholding
10th Apr 20177:00 amRNSCarillion JV awarded MoD contract
7th Apr 20174:14 pmRNSHolding(s) in Company
30th Mar 20178:07 amRNSHolding(s) in Company
29th Mar 20175:32 pmRNS2016 Annual Report & Accounts and 2017 AGM Notice
29th Mar 201712:37 pmRNSHolding(s) in Company
28th Mar 201712:25 pmRNSHolding(s) in Company
23rd Mar 20174:01 pmRNSHolding(s) in Company
20th Mar 20177:00 amRNSCarillion awarded £90m DIO contract in Cyprus
16th Mar 20178:28 amRNSHolding(s) in Company
16th Mar 20177:48 amRNSHolding(s) in Company
16th Mar 20177:46 amRNSHolding(s) in Company
14th Mar 20174:06 pmRNSHolding(s) in Company
3rd Mar 20179:25 amRNSJoint Venture awarded £490 million contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.